Integrative Care and Patient Outcomes for Cardiorenal Syndrome
Delve into the significance of integrative care for cardiorenal syndrome in addressing dual organ system challenges for better health.
Abstract
This educational post, from my perspective as Dr. Jimenez, explores the intricate relationship between the heart and the kidneys, a condition known as cardiorenal syndrome (CRS). I will guide you on a clear, clinically grounded journey to understand the complex hormonal “crosstalk” that occurs when heart failure leads to kidney dysfunction, and vice versa. We will unpack the pathophysiology of this condition, detailing the initial diagnostic workup, key physical assessment findings, and the underlying physiological mechanisms. We will explore the overlooked impact of venous congestion on organ perfusion, the evolution of forward vs. backward flow thinking in heart failure management, and how modern, evidence-based strategies—including diuretic therapy, guideline-directed medical therapy (GDMT), and advanced interventions—are applied. Throughout, I will connect these concepts to our unique, multidisciplinary model at Injury Medical Clinic. I, Dr. Alex Jimenez, work alongside our Medical Director, Dr. Maria Guadalupe Cardenas, MD, to integrate chiropractic care, functional medicine, and traditional medical oversight, providing a comprehensive understanding of why this syndrome occurs and how an integrative framework offers a path toward better management and improved patient outcomes.
Hello, I am Dr. Alex Jimenez. With a diverse background as a Doctor of Chiropractic (DC), an Advanced Practice Registered Nurse (APRN), and a board-certified Family Nurse Practitioner (FNP-BC), I have dedicated my career to understanding the body’s interconnected systems. My additional certifications in Functional Medicine (CFMP, IFMCP), Advanced Technology Neurology (ATN), and Cranial Cervical Spinal Technology (CCST) have reinforced my belief in a holistic, evidence-based approach to patient care. It’s this dedication that fuels my passion for understanding and sharing the latest findings from leading researchers.
At our practice, Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we pride ourselves on our unique, multidisciplinary setup. I work in close collaboration with Dr. Maria Guadalupe Cardenas, MD, our esteemed Medical Director and Collaborative Physician. Dr. Cardenas is Board Certified in Internal Medicine and brings over four decades of clinical experience (NPI #1164426749, Texas MD License #J2933). This collaborative model, common in integrative and injury care clinics, where an MD provides medical direction alongside a chiropractor, allows us to seamlessly integrate chiropractic care, functional medicine, personal injury rehabilitation, and primary medical services. Dr. Cardenas’s medical expertise provides an essential layer of diagnostic precision and management, ensuring our patients receive comprehensive, safe, and effective care.
Today, I want to share insights into a critical and often overlooked area of health: the profound connection between the heart and the kidneys, known as cardiorenal syndrome. I will be presenting the latest findings from leading researchers in the field, translating their complex work into an easy-to-understand journey for you, from diagnosis to advanced management.
Understanding the Heart-Kidney Tug-of-War
To truly grasp cardiorenal syndrome, we must first appreciate that both the heart and the kidneys are powerful endocrine organs. While we commonly associate the kidneys with hormone production, the heart also plays a vital endocrine role. It produces several natriuretic peptides, including:
- Atrial Natriuretic Peptide (ANP)
- B-type Natriuretic Peptide (BNP)
- C-type Natriuretic Peptide (CNP)
These peptides function in a negative feedback loop, much like other endocrine systems. Their primary purpose is to promote vasodilation (widening of blood vessels), natriuresis (excretion of sodium in the urine), and diuresis (excretion of water). Essentially, they are the body’s natural “relaxation” and fluid-shedding system.
On the other side of this tug-of-war are the kidneys, which regulate the Renin-Angiotensin-Aldosterone System (RAAS). This system releases hormones that have the opposite effect:
- Renin and Angiotensin: These cause powerful vasoconstriction, tightening blood vessels to maintain blood pressure.
- Aldosterone: This hormone promotes sodium and water retention, increasing blood volume.
In a healthy state, the heart’s natriuretic peptides and the kidney’s RAAS are in delicate balance. However, in heart failure, this balance is shattered. The kidneys, being the stronger endocrine organs in this battle, will win out over time. Theheart’ss natriuretic peptide system becomes overwhelmed, and the RAAS dominates, creating a state of chronic fluid retention and vasoconstriction. This is the essence of the heart-kidney crosstalk.
The Pathophysiological Web of Cardiorenal Syndrome
The journey into cardiorenal syndrome begins with heart failure. Regardless of its cause, heart failure immediately triggers two primary problems: a decrease in cardiac output (the amount of blood the heart pumps per minute) and an increase in preload (the volume of blood stretching the ventricles at the end of diastole). This rise in preload manifests as increased pressure in both the left and right sides of the heart.
The body perceives this drop in cardiac output as a critical threat, akin to blood loss from a traumatic injury. This triggers two powerful compensatory mechanisms:
- RAAS Activation: The kidneys sense reduced blood flow and kick the RAAS into high gear. They release renin and angiotensin to constrict blood vessels and raise blood pressure, and aldosterone to retain salt and water to “refill the tank.”
- Sympathetic Nervous System (SNS) Activation: The “fight-or-flight” response is initiated. The SNS releases inflammatory cytokines and stimulates the heart to beat faster. Remember the equation for cardiac output: Cardiac Output = Heart Rate × Stroke Volume. If stroke volume falls, the body compensates by increasing heart rate.
In the short term, these responses are life-saving. They are designed to manage acute crises. However, heart failure is a chronic condition. This constant activation turns these helpful compensatory mechanisms into maladaptive mechanisms that drive the disease forward.
The chronic inflammation from SNS activation and the relentless vasoconstriction from RAAS activation begin to damage the kidneys at a microscopic level. The inflammatory cytokines cause glomerular and interstitial damage within the nephrons—the kidney’s filtering units. Over time, this leads to sclerosis (scarring) and fibrosis, progressively destroying kidney function and leading to Chronic Kidney Disease (CKD). You can see how this becomes a vicious cycle: heart failure causes kidney damage, and the damaged kidneys further activate the RAAS, which in turn worsens heart failure. It’s a runaway train, with each system feeding the other’s dysfunction (Hoguet, 2024).
The Deeper Factors: Neurohormonal and Non-Hemodynamic Influences
Beyond the basic mechanics, several other factors intensify the heart-kidney conflict. We need to look at the neurohormonal changes and other, non-hemodynamic (not related to blood flow) factors that contribute to the damage.
Neurohormonal Imbalance
As discussed, the core issue is the predominance of RAAS. The kidneys’ drive to retain fluid and constrict vessels becomes so powerful that the heart’s natriuretic system is rendered ineffective. When we see elevated BNP levels in a patient’s lab work, we shouldn’t just think “fluid overload.” We should see it as a sign of a desperate endocrine response. The heart is screaming for help, releasing more and more BNP to counteract the dominant RAAS, much like how thyroid-stimulating hormone (TSH) levels climb in hypothyroidism as the pituitary gland tries to stimulate a failing thyroid.
Inflammation and Cellular Damage
The chronic activation of the sympathetic nervous system does more than raise the heart rate. It creates a highly inflammatory state, leading to a massive increase in reactive oxygen species (ROS). These are unstable molecules that cause cellular damage, a process known as oxidative stress.
This inflammation has devastating effects on both the heart and the kidneys:
- On the Heart: ROS contributes to myocardial scarring, further weakening the heart muscle, reducing cardiac output, and fueling even more RAAS activation.
- On the Kidneys: This process causes profound renal tubular injury. The damaged kidney cells trigger their own local RAAS activation, adding yet another layer to the problem. This injury leads to apoptosis (programmed cell death) and fibrosis (scar tissue formation). As healthy kidney tissue is replaced by scar tissue, function declines. Researchers have also observed vacuolization in the distal tubules—the formation of small cavities that reduce the surface area available for water removal, making the kidneys even less effective at producing urine (Hoguet, 2024).
Abdominal Congestion and The Rise of Venous Pressure
When we picture a patient with heart failure, we often think of swollen legs and ankles (peripheral edema). However, this is usually a late sign. Long before fluid accumulates in the extremities, it builds up in the abdomen. This is known as abdominal congestion.
The body packs this excess fluid into the splanchnic venous reservoir, which is the vast network of veins surrounding the liver, spleen, and intestines. This internal fluid buildup has serious consequences:
- Increased Intra-Abdominal Pressure: This pressure physically compresses the kidneys, impairing their ability to filter blood and produce urine.
- Bowel Edema: The intestinal walls become swollen with fluid, which can lead to malabsorption of nutrients and medications. It can also allow bacterial toxins to leak from the gut into the bloodstream, triggering more inflammation.
- Liver Congestion: The liver becomes engorged with blood, leading to impaired function and a condition known as congestive hepatopathy.
In the clinic, I often evaluate patients whose imaging shows abdominal wall edema, visceral congestion in the liver, spleen, and intestinal vasculature, and a plump inferior vena cava (IVC) that fails to collapse on inspiration. This reflects venous congestion—elevated venous pressures across the portal, splenic, and systemic beds. Physiologically, this congestion increases the effective circulatory volume, an extra burden the failing heart must manage. The outcome is higher filling pressures, reduced forward stroke volume, and worsening backward pressure transmission through the venous system.
Evolution of Forward-Backward Flow: What Right-Heart Hemodynamics Taught Us
Over the past four decades, data from pulmonary artery catheters and right-heart catheterizations have shifted our understanding. Early management overemphasized contractility. With greater hemodynamic profiling, we learned:
- Systemic vascular resistance (SVR) matters: judicious use of vasodilators can reduce afterload, thereby improving forward flow.
- The right ventricle (RV) is not an afterthought. It governs venous return, pulmonary pressures, and preload transfer to the left heart.
- Venous pressure acts as a central player: high right-sided pressures propagate backward through the IVC, portal, splenic, and, crucially, renal veins, thereby impairing organ perfusion and filtration.
Modern hemodynamic frameworks indicate that elevated right atrial pressure is associated with worse renal outcomes. Thus, if we target therapies only at contractility, we miss the harm caused by venous congestion. Decongestive strategies become central.
The Kidney’s Pressure Gradient: Why Venous Pressure Can Torpedo Filtration
The kidney’s filtration depends on a pressure gradient across the glomerulus: adequate afferent arterial pressure entering, balanced against low efferent venous pressure to allow filtration. When renal venous pressure rises, the gradient narrows, and filtration falls—despite adequate arterial inflow. This is the essence of a veno-renal problem.
Clinically, I’ve seen patients with acute decompensated heart failure (ADHF) whose creatinine improved dramatically—not because we pushed inotropes—but because we decongested the kidneys. This is why we now talk about progression from pre-renal (low arterial inflow) to cardio-renal (heart failure–mediated renal dysfunction) to veno-renal (venous hypertension–driven renal compromise). It reframes our targets: support forward flow and, equally important, lower venous pressures.
The Initial Diagnostic Workup: Assembling the Clinical Picture
When a patient presents with dyspnea, or shortness of breath, our first step is to gather objective data through a series of crucial laboratory tests to understand the full physiological context.
Essential Laboratory Investigations
- Complete Blood Count (CBC): This is fundamental. Anemia, for instance, can cause or exacerbate shortness of breath.
- Comprehensive Metabolic Panel (CMP): I always opt for a CMP. It includes liver function tests (AST, ALT, bilirubin). The liver and kidneys are, physiologically speaking, “ride or die” partners. In severe congestion, pressure backs up into the systemic circulation, causing hepatic congestion and elevated liver enzymes. Seeing this alongside poor kidney function helps confirm systemic congestion.
- Brain Natriuretic Peptide (BNP or Pro-BNP): This is a cornerstone for diagnosing heart failure. These peptides are released by the heart muscle when it is stretched. It’s a direct biomarker of cardiac strain.
- Lactate: an underutilized yet incredibly insightful marker. Elevated lactate is a fundamental indicator of poor perfusion. A high lactate tells me a patient is not only congested but also malperfusing, and I need to be more aggressive.
- Troponin: A chronically failing heart can”leak” small amounts of troponin. A massive spike suggests a new heart attack might be the cause of decompensation, while a low-level, chronic elevation is more in line with progressive heart failure.
- Urinalysis with Urine Microalbumin: My focus here is on protein. Significant proteinuria can indicate long-standing kidney damage. I’ve seen patients referred for heart failure who were later diagnosed with nephrotic syndrome, a completely different disease.
Essential Imaging and Functional Tests
- Echocardiogram (Echo): This ultrasound of the heart tells us about the heart’s structure and function, including the ejection fraction (EF).
- Renal Ultrasound: When a patient presents with acute kidney injury (AKI), we must rule out a post-obstructive process, such as hydronephrosis (swelling of the kidneys due to a backup of urine).
- 12-Lead Electrocardiogram (EKG): We look for signs of an acute MI and arrhythmias such as atrial fibrillation (A-Fib), which can trigger decompensated heart failure.
The Physical Assessment: Listening to the PPatient’sStory
The numbers from labs and imaging are critical, but the patient’s story and our physical findings are equally important.
Understanding Functional Limitations: The NYHA Classification
The New York Heart Association (NYHA) Functional Classification is a simple tool for quantifying symptom severity.
- Class I: No limitation of physical activity.
- Class II: Slight limitation. Comfortable at rest, but ordinary activity causes symptoms.
- Class III: Marked limitation. Comfortable at rest, but less-than-ordinary activity causes symptoms.
- Class IV: Unable to carry on any physical activity without discomfort. Symptoms may be present even at rest.
Key Signs and Symptoms of Congestion
- Orthopnea: Shortness of breath when lying flat. I ask, “How many pillows do you sleep on?” or “Are you still sleeping in your bed?”
- Paroxysmal Nocturnal Dyspnea (PND): Waking up suddenly at night, gasping for breath. Patients often describe it as a feeling of panic. I ask, “Do you ever wake up at night suddenly feeling like you can’t breathe or like you’re having a panic attack in your sleep?”
- Bendopnea: This is my favorite one to discuss. It is literally shortness of breath upon bending over (e.g., to tie a shoe), a specific sign of high intracardiac pressures.
- Dyspnea on Exertion (DOE): To get an accurate picture, I ask about daily functional activities: “Can you walk across a parking lot? Can you push a vacuum cleaner?”
- Other Signs: Weight gain, early satiety, abdominal bloating, and peripheral edema.
Identifying Malperfusion and Hemodynamic Profiles
Beyond congestion, we assess for malperfusion—inadequate blood flow to the organs. Signs include fatigue, intermittent confusion, and decreased urine output. Based on these findings, we classify patients into hemodynamic profiles:
- Warm and Wet: Good perfusion (warm) but congested (wet). (Most common).
- Cold and Wet: Poor perfusion (cold) and congested (wet). (Sickest).
- Warm and Dry: Good perfusion (warm) and not congested (dry). (Ideal).
- Cold and Dry: Poor perfusion (cold) but not congested (dry).
The Five Phenotypes of Cardiorenal Syndrome
To better understand the pathophysiology, cardiorenal syndrome is categorized into five types:
- Type 1 (Acute Cardiorenal Syndrome): Acute heart failure leads to AKI.
- Type 2 (Chronic Cardiorenal Syndrome): Chronic heart failure causes or worsens CKD.
- Type 3 (Acute Renocardiac Syndrome): An acute kidney injury causes acute heart failure.
- Type 4 (Chronic Renocardiac Syndrome): Chronic kidney disease leads to cardiac dysfunction.
- Type 5 (Secondary Cardiorenal Syndrome): A systemic condition (e.g., sepsis) causes both heart and kidney dysfunction.
The Cornerstone of CRS Management: Diuretic Therapy
When we manage patients with cardiorenal syndrome with fluid overload, diuretic therapy is the cornerstone of our treatment. The primary goal is to alleviate congestion by reducing fluid volume, which lowers heart filling pressures and left ventricular (LV) wall stress. However, loop diuretics activate the Renin-Angiotensin System (RAS), a crucial consideration.
Diuretic Pharmacology: Understanding Threshold and Ceiling Effects
To use diuretics effectively, we must grasp two concepts: the threshold and the ceiling.
- Threshold: This is the minimum concentration of a diuretic needed to produce an effect. Conditions like renal impairment and severe edema significantly raise this threshold. A patient with elevated creatinine will likely need a higher-than-usual dose to get a response.
- Ceiling: This is the maximum effective dose. Beyond this point, giving more diuretic only increases the risk of side effects. Recognizing when a patient has reached their ceiling dose is a critical signal to switch to a different class of diuretic rather than increasing the dose.
A Closer Look at Loop Diuretics
Loop diuretics—furosemide (Lasix), torsemide (Demadex), and bumetanide (Bumex)—are the workhorses of decongestion. Their oral potencies differ significantly:
- 40 mg of furosemide? 20 mg of torsemide 1 mg of bumetanide
This conversion is crucial. The real story lies in bioavailability. Oral fufurosemide’sioavailability is notoriously unpredictable (10-100%), especially in heart failure patients with gut edema. Because of this, I almost exclusively prescribe oral torsemide or bumetanide, which have a reliable bioavailability of 80-100%.
Timing is also critical. Giving a diuretic at bedtime increases the risk of falls. I advise my patients to take their first dose upon waking and their second dose about an hour after lunch.
Navigating Guideline-Directed Medical Therapy (GDMT) in CRS
For patients with CRS from heart failure, the most effective way to help the kidneys is to treat the heart with Guideline-Directed Medical Therapy (GDMT).
- eGFR > 30 mL/min/1.73m²: We can safely initiate ARNIs, ACE inhibitors, ARBs, and MRAs.
- eGFR > 20 mL/min/1.73m²: SGLT2 inhibitors can be initiated.
- eGFR < 30 mL/min/1.73 m²: Guidelines generally support withholding ARNIs, ACEi/ARBs, and MRAs, but SGLT2 inhibitors may be continued until the patient requires dialysis.
Advanced Therapies: Inotropes, Ultrafiltration, and Mechanical Support
When diuretics alonearen’tt enough, we must consider more advanced therapies.
Inotrope Support
Inotropes increase the heart’s contractions. A key indication is refractory oliguria (low urine output) despite optimal diuretic therapy.
- Milrinone: This is a potent vasodilator that reduces afterload on the RV, improving its function. This lowers central venous pressure, reduces pressure on the renal veins, and promotes filtration (H. Ellison, 2017).
- Dobutamine: This agent increases heart rate and contractility, thereby increasing cardiac output.
Ultrafiltration
When a patient is profoundly fluid overloaded and unresponsive to diuretics, we consider ultrafiltration. This mechanically removes fluid from the blood without stimulating the RAAS.
Mechanical Circulatory Support (MCS)
In severe cardiogenic shock, we may need temporary mechanical circulatory support, such as Impella (a small pump to unload the ventricle) or ECMO (full heart-lung support).
Beating the Odds: “Conquering Congestive Heart Failure”- Video
The Integrative Chiropractic and Functional Medicine Approach at Our Clinic
This is where our integrated model at Injury Medical Clinic excels. While Dr. Cardenas oversees medical management, my role focuses on supporting foundational systems.
As a chiropractor, I focus on the structural and neurological integrity of the body. Misalignments, particularly in the thoracic region, can affect sympathetic and parasympathetic nerve flow to the organs. By using specific chiropractic adjustments, we can help modulate autonomic nervous system (ANS) function, aiming to reduce the”fight-or-flight” sympathetic overdrive that contributes to RAAS activation and inflammation. Gentle, specific adjustments to the upper cervical and thoracic spine can promote a shift toward a parasympathetic (“rest and digest”) state, improving heart rate variability and lowering blood pressure.
Working collaboratively with Dr. Cardenas ensures that all medical aspects are managed to the highest standards. Her extensive experience is invaluable in navigating the complexities of diuretic regimens, GDMT, and managing comorbidities like hypertension and diabetes.
My functional medicine training allows us to dig even deeper. We look for the root causes of inflammation and oxidative stress through:
- Advanced Diagnostic Testing: Assessing inflammatory markers, nutrient deficiencies, and gut health.
- Targeted Nutritional Protocols: Designing anti-inflammatory eating plans rich in antioxidants.
- Professional-Grade Supplementation: Using targeted supplements like Coenzyme Q10 to support mitochondrial function in the heart and omega-3 fatty acids to reduce inflammation.
- Gut Health Restoration: Addressing bowel edema and “leaky gut” is crucial to reduce the systemic inflammatory burden.
By integrating chiropractic care (to optimize neurological function), traditional medicine (for acute management and oversight), and functional medicine (to address root-cause inflammation), we create a comprehensive, patient-centered plan. We are not just treating a heart and a kidney; we are treating a whole person whose systems are intricately connected.
References
- H. Ellison, G. L. H. (2017). Diuretic Resistance. American Journal of Kidney Diseases, 69(1), 136-146.
- Hoguet, B. (2024). The heart and kidney crosstalk: The pathophysiology and management of cardiorenal syndrome. American Association of Nurse Practitioners (AANP).
- House, A. A., Anand, I., Bellomo, R., Cruz, D., Bobek, I., Anker, S. D., … & Haapio, M. (2010). Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrology Dialysis Transplantation, 25(5), 1416–1420.
- Jimenez, A. (n.d.). Clinical observations and integrative approaches – Injury Medical Clinic PA.
- Jimenez, A. (n.d.). Professional profile and interdisciplinary work – Dr. Alex Jimenez.
- Ronco, C., McCullough, P., Anker, S. D., Anand, I., Aspromonte, N., Bagshaw, S. M., … & Rosner, M. (2010). Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative. European Heart Journal, 31(6), 703–711.
- Thibodeau, J. T., & Drazner, M. H. (2018). The Role of the Clinical Examination in Patients With Heart Failure. JACC: Heart Failure, 6(7), 543-551.
SEO Tags: Cardiorenal Syndrome, Heart Failure, Chronic Kidney Disease, Integrative Chiropractic, Functional Medicine, Dr. Alex Jimenez, Dr. Maria Guadalupe Cardenas, El Paso TX, Pathophysiology, RAAS, Abdominal Congestion, Venous Congestion, Neurohormonal Activation, Heart-Kidney Crosstalk, Internal Medicine, Multidisciplinary Care, Diuretic Therapy, Guideline-Directed Medical Therapy, GDMT, SGLT2 inhibitors, Dyspnea, Bendopnea, NYHA Class, Malperfusion, Right Ventricle, Glomerular Filtration Gradient, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, Chiropractic and Heart Failure, Oxidative Stress
Post Disclaimers
General Disclaimer, Licenses and Board Certifications *
Professional Scope of Practice *
The information herein on "Integrative Care and Patient Outcomes for Cardiorenal Syndrome" is not intended to replace a one-on-one relationship with a qualified health care professional or licensed physician and is not medical advice. We encourage you to make healthcare decisions based on your research and partnership with a qualified healthcare professional.
Blog Information & Scope Discussions
Welcome to El Paso's Premier Wellness and Injury Care Clinic & Wellness Blog, where Dr. Alex Jimenez, DC, FNP-C, a Multi-State board-certified Family Practice Nurse Practitioner (FNP-BC) and Chiropractor (DC), presents insights on how our multidisciplinary team is dedicated to holistic healing and personalized care. Our practice aligns with evidence-based treatment protocols inspired by integrative medicine principles, similar to those on this site and on our family practice-based chiromed.com site, focusing on naturally restoring health for patients of all ages.
Our areas of multidisciplinary practice include Wellness & Nutrition, Chronic Pain, Personal Injury, Auto Accident Care, Work Injuries, Back Injury, Low Back Pain, Neck Pain, Migraine Headaches, Sports Injuries, Severe Sciatica, Scoliosis, Complex Herniated Discs, Fibromyalgia, Chronic Pain, Complex Injuries, Stress Management, Functional Medicine Treatments, and in-scope care protocols.
Our information scope is multidisciplinary, focusing on musculoskeletal and physical medicine; wellness; contributing etiological viscerosomatic disturbances within clinical presentations; associated somato-visceral reflex clinical dynamics; subluxation complexes; sensitive health issues; and functional medicine articles, topics, and discussions.
We provide and present clinical collaboration with specialists from various disciplines. Each specialist is governed by their professional scope of practice and licensure jurisdiction. We use functional health & wellness protocols to treat and support care for musculoskeletal injuries or disorders.
Our videos, posts, topics, and insights address clinical matters and issues that directly or indirectly relate to our clinical scope of practice.
Our office has made a reasonable effort to provide supportive citations and has identified relevant research studies that support our posts. We provide copies of supporting research studies upon request to regulatory boards and the public.
We understand that we cover matters that require an additional explanation of how they may assist in a particular care plan or treatment protocol; therefore, to discuss the subject matter above further, please feel free to ask Dr. Alex Jimenez, DC, APRN, FNP-BC, or contact us at 915-850-0900.
We are here to help you and your family.
Blessings
Dr. Alex Jimenez DC, MSACP, APRN, FNP-BC*, CCST, IFMCP, CFMP, ATN
email: [email protected]
Multidisciplinary Licensing & Board Certifications:
Licensed as a Doctor of Chiropractic (DC) in Texas & New Mexico*
Texas DC License #: TX5807, Verified: TX5807
New Mexico DC License #: NM-DC2182, Verified: NM-DC2182
Multi-State Advanced Practice Registered Nurse (APRN*) in Texas & Multi-States
Multi-state Compact APRN License by Endorsement (42 States)
Texas APRN License #: 1191402, Verified: 1191402 *
Florida APRN License #: 11043890, Verified: APRN11043890 *
Colorado License #: C-APN.0105610-C-NP, Verified: C-APN.0105610-C-NP
New York License #: N25929, Verified N25929
License Verification Link: Nursys License Verifier
* Prescriptive Authority Authorized
ANCC FNP-BC: Board Certified Nurse Practitioner*
Compact Status: Multi-State License: Authorized to Practice in 40 States*
Graduate with Honors: ICHS: MSN-FNP (Family Nurse Practitioner Program)
Degree Granted. Master's in Family Practice MSN Diploma (Cum Laude)
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
(Board Certified: Family Practice Nurse Practitioner—Multistate)*
(Licensed Nurse Practitioner & Chiropractor - Multistate)*
Clinical Director
Digital Business Card
Dr. Maria Cardenas, MD
(Board Certified: Internal Medicine)
(Licensed Medical Doctor)
Medical Director, Clinical Director & Collaborative Physician
NPI # 1164426749
MD License #: J2933
Licenses and Board Certifications:
MD: Medical Doctor
DC: Doctor of Chiropractic
APRNP: Advanced Practice Registered Nurse
FNP-BC: Family Practice Specialization (Multi-State Board Certified)
RN: Registered Nurse (Multi-State Compact License)
CFMP: Certified Functional Medicine Provider
MSN-FNP: Master of Science in Family Practice Medicine
MSACP: Master of Science in Advanced Clinical Practice
IFMCP: Institute of Functional Medicine
CCST: Certified Chiropractic Spinal Trauma
ATN: Advanced Translational Neutrogenomics
Memberships & Associations:
TCA: Texas Chiropractic Association: Member ID: 104311
AANP: American Association of Nurse Practitioners: Member ID: 2198960
ANA: American Nurse Association: Member ID: 06458222 (District TX01)
TNA: Texas Nurse Association: Member ID: 06458222
NPI: 1205907805
| Primary Taxonomy | Selected Taxonomy | State | License Number |
|---|---|---|---|
| No | 111N00000X - Chiropractor | NM | DC2182 |
| Yes | 111N00000X - Chiropractor | TX | DC5807 |
| Yes | 363LF0000X - Nurse Practitioner - Family | TX | 1191402 |
| Yes | 363LF0000X - Nurse Practitioner - Family | FL | 11043890 |
| Yes | 363LF0000X - Nurse Practitioner - Family | CO | C-APN.0105610-C-NP |
| Yes | 363LF0000X - Nurse Practitioner - Family | NY | N25929 |
Dr. Alex Jimenez, DC, APRN, FNP-BC*, CFMP, IFMCP, ATN, CCST
(Board Certified: Family Practice Nurse Practitioner—Multistate)*
(Licensed Nurse Practitioner & Chiropractor - Multistate)*
Clinical Director
Digital Business Card
Dr. Maria Cardenas, MD
(Board Certified: Internal Medicine)*
(Licensed Medical Doctor)*
Medical Director, Clinical Director & Collaborative Physician
NPI # 1164426749
MD License #: J2933
Comments are closed.